The KLOW Blend is strictly for laboratory research and is commonly employed in the following investigational areas:

Endothelial Function and Angiogenesis

Research utilizes this blend to study the differentiation and proliferation of endothelial cells. Studies focus on measuring the expression of angiogenic factors, particularly VEGFR2 activation and tube formation capacity, to quantify how the combined presence of BPC-157 and GHK-Cu influences vascular repair signaling.

Cytoskeletal Organization and Cell Migration

The TB-500 component is utilized to investigate actin sequestration. Researchers measure the ratio of F-actin to G-actin in motile cells to determine how upregulation of Thymosin Beta-4 influences cytoskeletal reorganization, a critical step in cellular migration and wound re-epithelialization.

Inflammation and Stress Response

Investigations employ the KPV and GHK-Cu components to characterize anti-inflammatory pathways. Assays quantify the modulation of the MAPK/NF-kB pathway and oxidative stress markers to evaluate the peptide blend’s ability to mitigate inflammatory cell infiltration and cellular apoptosis in stress models.

Tissue Remodeling and Collagen Dynamics

In vitro models employ this blend to characterize extracellular matrix remodeling. Investigators quantify the rate of defect closure and collagen synthesis in fibroblast cultures, examining how GHK-Cu and BPC-157 influence tendon outgrowth and granulation tissue formation.

Pathway / Mechanistic Context

The primary mechanistic context for the KLOW Blend in research settings involves the multi-modal modulation of vascular signaling, cytoskeletal plasticity, and inflammatory mediation.

• VEGF/NO Axis: BPC-157 and GHK-Cu are investigated for their ability to interact with the nitric oxide (NO) pathway and upregulate VEGFR2 expression, potentially stimulating vessel formation.
• Actin Sequestration: TB-500 acts by binding to monomeric G-actin, preventing its polymerization into F-actin filaments, a buffering mechanism critical for cell motility.
• NF-kB Modulation: KPV is studied for its specific ability to downregulate the NF-kB and MAPK pathways, serving as a chemical probe for reducing inflammatory signaling in keratinocytes and intestinal cells.

Preclinical Research Summary

Published preclinical literature documents investigations of the components within the KLOW Blend across experimental models for pathway characterization and endpoint measurement:

• Wound Healing Models: Extensive studies highlight the role of these peptides in accelerating the healing of complex injuries, including scalds and tendon defects. Data suggests they promote cell proliferation, angiogenesis, and collagen synthesis.
• Ischemic Tissue Models: In experimental ischemia, data indicates BPC-157 may preserve tissue viability. Endpoints measured include the reduction of oxidative stress markers and protection against organ damage in reperfusion injury models.
• Inflammatory Models: Research utilizing KPV indicates potential efficacy in alleviating ulcerative colitis and skin inflammation via PepT1-targeted delivery and modulation of pro-inflammatory cytokines.

Form & Analytical Testing

This material is produced via solid-phase peptide synthesis (SPPS) and supplied as a lyophilized (freeze-dried) powder.

• Lyophilization: Removes water content under vacuum to maintain compound integrity and extend shelf-life.
• Identity Verification: Each lot undergoes Mass Spectrometry (MS) to confirm the presence of peptide components.
• Purity Verification: High-Performance Liquid Chromatography (HPLC) is performed to ensure the product meets the purity standard required for reproducible research data.

Referenced Citations

References are provided for informational purposes only and are not clinical claims.

1. Hsieh, M.-J., et al. (2016). Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Journal of Molecular Medicine.
2. Dou, Y., Lee, A., Zhu, L., Morton, J., & Ladiges, W. (2020). The potential of GHK as an anti-aging peptide. Aging Pathobiology and Therapeutics.
3. Wang, X., et al. (2017). GHK‐Cu‐liposomes accelerate scald wound healing in mice by promoting cell proliferation and angiogenesis. Wound Repair and Regeneration.
4. Malinda, K. M., Goldstein, A. L., & Kueinman, H. K. (1997). Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells. The FASEB Journal.
5. Pickart, L., & Margolina, A. (2018). Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences.
6. Chang, C.-H., Tsai, W.-C., Lin, M.-S., Hsu, Y.-H., & Pang, J.-H. S. (2011). The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology.
7. Xue, B., Leyrat, C., Grimes, J. M., & Robinson, R. C. (2014). Structural basis of thymosin-beta4/profilin exchange leading to actin filament polymerization. Proceedings of the National Academy of Sciences.
8. Maquart, F.-X., Pickart, L., Laurent, M., Gillery, P., Monboisse, J.-C., & Borel, J.-P. (1988). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide‐copper complex glycyl‐L‐histidyl‐L‐lysine‐Cu2+. FEBS Letters.
9. Seiwerth, S., et al. (2021). Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Frontiers in Pharmacology.
10. Malinda, K. M., et al. (1999). Thymosin beta4 accelerates wound healing. Journal of Investigative Dermatology.
11. Demirtaş, H., Özer, A., Yıldırım, A. K., Dursun, A. D., Sezen, Ş. C., & Arslan, M. (2025). Protective Effects of BPC 157 on Liver, Kidney, and Lung Distant Organ Damage in Rats with Experimental Lower-Extremity Ischemia–Reperfusion Injury. Medicina.
12. Evans, M. A., et al. (2013). Thymosin beta4-sulfoxide attenuates inflammatory cell infiltration and promotes cardiac wound healing. Nature Communications.
13. Dalmasso, G., Charrier–Hisamuddin, L., Thu Nguyen, H. T., Yan, Y., Sitaraman, S., & Merlin, D. (2008). PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation. Gastroenterology.
14. Xiao, B., et al. (2017). Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis. Molecular Therapy.
15. Pickart, L., Vasquez-Soltero, J. M., & Margolina, A. (2012). The Human Tripeptide GHK-Cu in Prevention of Oxidative Stress and Degenerative Conditions of Aging: Implications for Cognitive Health. Oxidative Medicine and Cellular Longevity.
16. Vukojevic, J., et al. (2022). Pentadecapeptide BPC 157 and the central nervous system. Neural Regeneration Research.
17. Kim, S., Choi, J., & Kwon, J. (2023). Thymosin Beta 4 Protects Hippocampal Neuronal Cells against PrP (106–126) via Neurotrophic Factor Signaling. Molecules.
18. Pickart, L., Vasquez-Soltero, J. M., & Margolina, A. (2015). GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International.
19. Huang, T., et al. (2015). Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro. Drug Design, Development and Therapy.
20. Böhm, M., & Luger, T. (2019). Are melanocortin peptides future therapeutics for cutaneous wound healing? Experimental Dermatology.
21. Sharma, S., Anwar, M. F., Dinda, A., Singhal, M., & Malik, A. (2019). In Vitro and in Vivo Studies of pH-Sensitive GHK-Cu-Incorporated Polyaspartic and Polyacrylic Acid Superabsorbent Polymer. ACS Omega.
22. Sung, J., Ju, S.-Y., Park, S., Jung, W.-K., Je, J.-Y., & Lee, S.-J. (2025). Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway. Tissue and Cell.

• Stable at room temperature for up to 90 days. For long-term storage, keep at -20°C (-4°F) or colder.
• Once mixed with a solvent (e.g., bacteriostatic water), the solution must be stored at 4 °C (39°F) and utilized within 30 days. Avoid repeated freeze-thaw cycles, as this degrades the peptide structure.

RESEARCH USE ONLY

This product is intended strictly for laboratory research use only. It is not for human or veterinary use. It is not intended for diagnosis, treatment, cure, or prevention of any disease. All purchases are subject to our Terms of Service and Purity Guarantee.

No COAs available for this product.